The monoclonal antibody teprotumumab has been shown to be effective in chronic thyroid eye disease, reducing double vision and proptosis.
Continue reading
The latest in clinical vision science, curated by Dr. Jade Marie Lasiste
The monoclonal antibody teprotumumab has been shown to be effective in chronic thyroid eye disease, reducing double vision and proptosis.
Continue readingThis study shows that in children with myopia and aged 8 to 13 years old, red light therapy can be a safe and effective new alternative treatment for myopia control.
Continue readingAsymptomatic contact lens wearers may have undiagnosed eye disease and contact lens wear-related complications and may benefit from routine screening.
Continue readingWith this new modality, a greater view of the retina is available.
Continue readingMeibomian gland dropout can differentiate, in contact lens-wearers, those who have dry eye disease.
Continue readingUsed for attention deficit-hyperactivity disorder (ADHD) and narcolepsy, the drug has also shown potential use in eliminating some cognitive artifacts
Continue readingIn patients with obstructive sleep apnea and normal intraocular pressures, imaging of the optic nerve showed some changes associated with
Continue readingThe eyes do not seem to be a preferred site of entry or infection of the novel SARS-CoV2 virus.
Continue readingEye doctors are more at risk for coronavirus infection. Here are some measures that can be done to ameliorate that
Continue readingA large retrospective study seeks to analyze if there is evidence for the current practices opined by ophthalmologists.
Continue reading